WebThe treatment of chronic idiopathic thrombocytopenic purpura (ITP) is difficult in those unresponsive to corticosteroids and/or splenectomy. We attempted to induce durable … WebSep 2, 2024 · After 6 months of mycophenolate mofetil therapy, the dose for all patients who had a complete response to mycophenolate mofetil (platelet count >100×10 9 per …

Mycophenolate Mofetil for First-Line Treatment of …

WebDec 15, 2024 · Mycophenolate in combination with corticosteroids may be efficacious and tolerable as first-line treatment for patients with immune thrombocytopenia. ... (median … Webthrombocytopenic purpura (ITP) Immune thrombocytopenic purpura (ITP) is defined by a low platelet count and an increased risk of bleeding. Fatal bleeding is rare and occurs more frequently in elderly patients and in those with severe thrombocytopenia. Although treatment for ITP is strictly individualised, specific therapy for ITP may not be thierache du centre.fr

Mycophenolate Shows Promise in Immune Thrombocytopenia

WebThe most common treatment modality that has been used in ITP is immune suppression. This has been achieved using corticosteroids, immune suppressants such as … WebSep 22, 2016 · The optimal dose of rituximab for ITP treatment has not been established. We use 375 mg/m 2 once per week × 4 weeks, but lower doses may be effective ( Table … WebMycophenolate mofetil 250 mg twice daily was insufficient to induce a prolonged response. In this article, we describe a patient with severe chronic ITP that was treated with rituximab. The platelet count started to decrease 5 months after rituximab therapy, low dose therapy with mycophenolate thierache mask